GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
6NB7 | 6NB7 | SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2) | |
6NB6 | 6NB6 | SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1) | |
6NB4 | 6NB4 | MERS-CoV S complex with human neutralizing LCA60 antibody Fab fragment (state 2) | |
6NB3 | 6NB3 | MERS-CoV complex with human neutralizing LCA60 antibody Fab fragment (state 1) | |
6NAE | 6NAE | Crystal Structure of Ebola zaire GP protein with bound ARN0074898 | |
6NAE | 6NAE | Crystal Structure of Ebola zaire GP protein with bound ARN0074898 | |
6N9T | 6N9T | Structure of a peptide-based photo-affinity cross-linker with Herceptin Fc | Immunoglobulin G1 FC, Photo-affinity peptide |
6N6B | 6N6B | The complex crystal structure of neuraminidase from A/Minnesota/11/2010 with B10 antibody. | |
6N5E | 6N5E | Broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope | |
6N5B | 6N5B | Broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope | |
6N51 | 6N51 | Metabotropic Glutamate Receptor 5 bound to L-quisqualate and Nb43 | |
6N50 | 6N50 | Metabotropic Glutamate Receptor 5 Extracellular Domain in Complex with Nb43 and L-quisqualic acid | |
6N4Y | 6N4Y | Metabotropic Glutamate Receptor 5 Extracellular Domain with Nb43 | |
6N35 | 6N35 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
6N35 | 6N35 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
6N2X | 6N2X | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
6N2X | 6N2X | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
6N1W | 6N1W | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | |
6N1V | 6N1V | Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | |
6MZJ | 6MZJ | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer, 2 Fabs bound, sharpened map | |
6MZJ | 6MZJ | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer, 2 Fabs bound, sharpened map | |
6MYY | 6MYY | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer, 3 Fabs bound, sharpened map | |
6MYY | 6MYY | Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer, 3 Fabs bound, sharpened map | |
6MYV | 6MYV | Sialidase26 co-crystallized with DANA-Gc | |
6MYA | 6MYA | Crystal structure of InvbP.18715.a.KN11: Influenza hemagglutinin from strain A/Almaty/32/1998 | |
6MWR | 6MWR | Recognition of MHC-like molecule | |
6MVL | 6MVL | Crystal structure of VISTA bound to a pH-selective antibody Fab fragment | |
6MUG | 6MUG | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom | |
6MUF | 6MUF | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom | |
6MUB | 6MUB | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
6MUB | 6MUB | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
6MU8 | 6MU8 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom | |
6MU7 | 6MU7 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-818251 in Complex with Human Antibodies 3H109L and 35O22 at 3.1 Angstrom | |
6MU6 | 6MU6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom | |
6MU3 | 6MU3 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
6MU3 | 6MU3 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
6MTN | 6MTN | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom | |
6MTJ | 6MTJ | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom | |
6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
6MSU | 6MSU | Integrin alphaVBeta3 in complex with EETI-II 2.5F | |
6MSS | 6MSS | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | |
6MSL | 6MSL | Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D | |
6MRV | 6MRV | Sialidase26 co-crystallized with DANA | |
6MPH | 6MPH | Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | |
6MPG | 6MPG | Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | |
6MNF | 6MNF | Anti-HIV-1 Fab 2G12 + Man8 re-refinement | |
6MN7 | 6MN7 | Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment | |
6MLM | 6MLM | H7 HA0 in complex with Fv from H7.5 IgG | |
6ML8 | 6ML8 | Crystal structure of hemagglutinin from H1N1 Influenza A virus A/Denver/57 bound to the C05 antibody |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024